Dougherty’s Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States.
Weak fundamentals or lack of information.
Share Price & News
How has Dougherty's Pharmacy's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MYDP's share price has been volatile over the past 3 months.
7 Day Return
US Consumer Retailing
1 Year Return
US Consumer Retailing
Return vs Industry: MYDP underperformed the US Consumer Retailing industry which returned 16.2% over the past year.
Return vs Market: MYDP underperformed the US Market which returned 9.9% over the past year.
Price Volatility Vs. Market
How volatile is Dougherty's Pharmacy's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Dougherty's Pharmacy undervalued compared to its fair value and its price relative to the market?
Share Price vs. Fair Value
Below Fair Value: MYDP ($0.01) is trading above our estimate of fair value ($0)
Significantly Below Fair Value: MYDP is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MYDP is unprofitable, so we can't compare its PE Ratio to the Consumer Retailing industry average.
PE vs Market: MYDP is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MYDP's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MYDP has negative assets, so we can't compare its PB Ratio to the US Consumer Retailing industry average.
How is Dougherty's Pharmacy forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Consumer Retailing industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dougherty's Pharmacy has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of MYDP’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Dougherty's Pharmacy's filings and announcements here.
- Explore growth companies in the Consumer Retailing industry.
How has Dougherty's Pharmacy performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: MYDP is currently unprofitable.
Growing Profit Margin: MYDP is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MYDP's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare MYDP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MYDP is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (4.1%).
Return on Equity
High ROE: MYDP's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is Dougherty's Pharmacy's financial position?
Financial Position Analysis
Short Term Liabilities: MYDP has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: MYDP has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: MYDP has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: MYDP's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if MYDP has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MYDP has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Dougherty's Pharmacy's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MYDP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MYDP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MYDP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MYDP's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MYDP's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Stewart Edington (50yo)
Mr. Stewart I. Edington serves as Chief Executive Officer at Dougherty's Pharmacy, Inc. Mr. Edington served as President and Interim Chief Financial Officer at Dougherty's Pharmacy, Inc. since February 07 ...
|Chairman of the Board||18.25yrs||US$101.18k||7.92% $16.5k|
|Chief Executive Officer||1.33yrs||no data||no data|
|Managing Director of Business Development||2.33yrs||no data||no data|
|Secretary||no data||no data||no data|
|Controller||no data||no data||no data|
|Executive Vice President of Sales and Marketing||no data||no data||no data|
Experienced Management: MYDP's management team is considered experienced (2.3 years average tenure).
|Chairman of the Board||18.25yrs||US$101.18k||7.92% $16.5k|
|Independent Director||16yrs||US$22.68k||1.57% $3.3k|
|Independent Director||15.42yrs||US$13.18k||0.27% $564.1|
|Independent Director||2.83yrs||US$12.00k||17.31% $36.0k|
Experienced Board: MYDP's board of directors are seasoned and experienced ( 15.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Dougherty's Pharmacy, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Dougherty's Pharmacy, Inc.
- Ticker: MYDP
- Exchange: OTCPK
- Founded: 1929
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: US$207.881k
- Shares outstanding: 23.10m
- Website: https://www.doughertys.com
Number of Employees
- Dougherty's Pharmacy, Inc.
- 5924 Royal Lane
- Suite 250
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MYDP||OTCPK (Pink Sheets LLC)||Yes||Class A Common Stock||US||USD||Nov 1999|
Dougherty’s Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty’s Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty’s Pharmacy, Inc. in May 2017. Dougherty’s Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas. On August 28, 2019, Dougherty's Pharmacy, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas. It is in joint administration with Dougherty's Holdings, Inc.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/02 11:17|
|End of Day Share Price||2020/05/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.